(redirected from DMARD)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.
Related to DMARD: ACR20


1. any synthetic, semisynthetic, or natural chemical substance used in the treatment, prevention, or diagnosis of disease, or for other medical reasons
2. a chemical substance, esp a narcotic, taken for the pleasant effects it produces
3. drug on the market a commodity available in excess of the demands of the market
Collins Discovery Encyclopedia, 1st edition © HarperCollins Publishers 2005


Any substance used internally or externally as a medicine for the treatment, cure, or prevention of a disease.
A narcotic preparation.
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.


principle of evil. [Zoroastrianism: Leach, 325]
See: Evil
Allusions—Cultural, Literary, Biblical, and Historical: A Thematic Dictionary. Copyright 2008 The Gale Group, Inc. All rights reserved.


The interpretation of drugs in your dreams depends on the relationship you have with drugs in your daily life and whether they are doctor prescribed or not. If you are a drug user, then the drugs are an extension of what you normally do, and you need to look at the other details of your dream to get a good interpretation. However, if you use drugs rarely or never, then this dream could represent a need to get well, to escape from daily stress, and a desire to get quick relief. The drugs could be suggesting a need for healing and getting in balance. Your unconscious mind may be suggesting outrageous things in hopes that you get the message to “have fun, dream dreams, and get out of your own head!” Please keep in mind that the purpose of dreams is to raise our consciousness and to assist us in having better lives. The message in the dream about drug use is most likely not encouraging you to use drugs but it may represent a need to feel better or get better.
Bedside Dream Dictionary by Silvana Amar Copyright © 2007 by Skyhorse Publishing, Inc.
References in periodicals archive ?
Methotrexate (MTX) and hydroxychloroquine (HCQ) followed by sulphasalazine (SSZ) were the preferred DMARDs in the cohort.
There were 81 THAs with 11 of those performed on patients on biologic DMARDs and 339 TKAs with 37 being performed on patients on biologic DMARDs.
In both patients receiving MTX monotherapy and those receiving multiple traditional DMARD therapy, there was no significant association between use of SC MTX and elevated ALT and AST levels.
Some studies exploring patients' beliefs about DMARDs have revealed anxieties about using these agents, which were perceived as powerful and toxic.
Conventional synthetic DMARDs are ineffective for these patients, while in contrast all of the biologic DMARDs are effective, but the TNF inhibitors have an edge because of greater experience with the class in this setting.
The use of tocilizumab, a humanized, monoclonal antibody against the IL-6 receptor, has demonstrated efficacy in open-label trials of SJIA, and in 2008 a trial of 56 SJIA patients with persistent disease despite DMARD or biologic therapy was conducted in which tocilizumab was administered as monotherapy to all patients during the 6 week open-label, lead-in phase followed by randomization to placebo for patients who achieved at least an ACR Pedi 30 response for the following 12 weeks or until disease flare.
The SABER researchers plan to look at what happened to prednisone dosing when the RA patients went on anti-TNF therapy or an additional nonbiologic DMARD. Dr.
Because treatment response usually depends on the disease duration, a Cox regression analysis was performed to find out the factors affecting the duration of DMARD application in the second part of the study.
There is a positive link between RA pathogenesis and IL-18 gene expression.16 The aim of our study was to evaluate the expression of IL-18 in RA patients on DMARD therapy compared to expression in healthy controls, in context with local population.
At the completion of this process, high-risk medication monitoring was selected as the laboratory medicine quality gap topic for future intervention, with ALT, AST, CBC, and SCr laboratory monitoring for DMARD therapy as the subtopic.
The study found that over 15 years, just 1.5% of patients on DMARDs developed dementia, compared with 3% of those not taking the drugs.
Scientists analysed the records of patients taking disease-modifying antirheumatic drugs (DMARDs) and those who were not.